國立虎尾科技大學 |

Accelerated Path to Cures

紀錄類型:	書目-語言資料,印刷品 : Monograph/item
正題名/作者:	Accelerated Path to Cures/ edited by Josep Bassaganya-Riera.
其他作者:	Bassaganya-Riera, Josep.
面頁冊數:	VIII, 82 p. 11 illus. in color.online resource. :
Contained By:	Springer Nature eBook
標題:	Immunology. -
電子資源:	https://doi.org/10.1007/978-3-319-73238-1
ISBN:	9783319732381

Accelerated Path to Cures
Accelerated Path to Cures[electronic resource] /edited by Josep Bassaganya-Riera. - 1st ed. 2018. - VIII, 82 p. 11 illus. in color.online resource.

Chapter 1: Introduction to Accelerated Path to Cures and Precision Medicine in Inflammatory Bowel Disease -- Chapter 2: Computer-Aided Drug Discovery -- Chapter 3: Preclinical Studies: Efficacy and Safety -- Chapter 4: From Nutritional Immunology to Drug Development -- Chapter 5: Development of Synthetic Patient Populations and In Silico Clinical Trials.

Accelerated Path to Cures provides a transformative perspective on the power of combining advanced computational technologies, modeling, bioinformatics and machine learning approaches with nonclinical and clinical experimentation to accelerate drug development. This book discusses the application of advanced modeling technologies, from target identification and validation to nonclinical studies in animals to Phase 1-3 human clinical trials and post-approval monitoring, as alternative models of drug development. As a case of successful integration of computational modeling and drug development, we discuss the development of oral small molecule therapeutics for inflammatory bowel disease, from the application of docking studies to screening new chemical entities to the development of next-generation in silico human clinical trials from large-scale clinical data. Additionally, this book illustrates how modeling techniques, machine learning, and informatics can be utilized effectively at each stage of drug development to advance the progress towards predictive, preventive, personalized, precision medicine, and thus provide a successful framework for Path to Cures. .

ISBN: 9783319732381

Standard No.: 10.1007/978-3-319-73238-1doiSubjects--Topical Terms:

592892
Immunology.

LC Class. No.: QR180-189.5

Dewey Class. No.: 616.079

Accelerated Path to Cures
LDR:02890nam a22003975i 4500 001 992441
003 DE-He213
005 20200706155217.0
007 cr nn 008mamaa
008 201225s2018 gw | s |||| 0|eng d
020 $a 9783319732381 $9 978-3-319-73238-1
024 7 $a 10.1007/978-3-319-73238-1 $2 doi
035 $a 978-3-319-73238-1
050 4 $a QR180-189.5
072 7 $a MJCM $2 bicssc
072 7 $a MED044000 $2 bisacsh
072 7 $a MJCM $2 thema
082 0 4 $a 616.079 $2 23
245 1 0 $a Accelerated Path to Cures $h [electronic resource] / $c edited by Josep Bassaganya-Riera.
250 $a 1st ed. 2018.
264 1 $a Cham : $b Springer International Publishing : $b Imprint: Springer, $c 2018.
300 $a VIII, 82 p. 11 illus. in color. $b online resource.
336 $a text $b txt $2 rdacontent
337 $a computer $b c $2 rdamedia
338 $a online resource $b cr $2 rdacarrier
347 $a text file $b PDF $2 rda
505 0 $a Chapter 1: Introduction to Accelerated Path to Cures and Precision Medicine in Inflammatory Bowel Disease -- Chapter 2: Computer-Aided Drug Discovery -- Chapter 3: Preclinical Studies: Efficacy and Safety -- Chapter 4: From Nutritional Immunology to Drug Development -- Chapter 5: Development of Synthetic Patient Populations and In Silico Clinical Trials.
520 $a Accelerated Path to Cures provides a transformative perspective on the power of combining advanced computational technologies, modeling, bioinformatics and machine learning approaches with nonclinical and clinical experimentation to accelerate drug development. This book discusses the application of advanced modeling technologies, from target identification and validation to nonclinical studies in animals to Phase 1-3 human clinical trials and post-approval monitoring, as alternative models of drug development. As a case of successful integration of computational modeling and drug development, we discuss the development of oral small molecule therapeutics for inflammatory bowel disease, from the application of docking studies to screening new chemical entities to the development of next-generation in silico human clinical trials from large-scale clinical data. Additionally, this book illustrates how modeling techniques, machine learning, and informatics can be utilized effectively at each stage of drug development to advance the progress towards predictive, preventive, personalized, precision medicine, and thus provide a successful framework for Path to Cures. .
650 0 $a Immunology. $3 592892
650 0 $a Bioinformatics. $3 583857
650 0 $a Health informatics. $3 1064466
650 0 $a Bioinformatics . $3 1253897
650 0 $a Computational biology . $3 1253898
650 2 4 $a Computational Biology/Bioinformatics. $3 677363
650 2 4 $a Health Informatics. $3 593963
650 2 4 $a Computer Appl. in Life Sciences. $3 593908
700 1 $a Bassaganya-Riera, Josep. $4 edt $4 http://id.loc.gov/vocabulary/relators/edt $3 1203436
710 2 $a SpringerLink (Online service) $3 593884
773 0 $t Springer Nature eBook
776 0 8 $i Printed edition: $z 9783319732374
776 0 8 $i Printed edition: $z 9783319732398
776 0 8 $i Printed edition: $z 9783030103392
856 4 0 $u https://doi.org/10.1007/978-3-319-73238-1
912 $a ZDB-2-SBL
912 $a ZDB-2-SXB
950 $a Biomedical and Life Sciences (SpringerNature-11642)
950 $a Biomedical and Life Sciences (R0) (SpringerNature-43708)